Filing Details

Accession Number:
0001179110-17-007224
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-15 20:13:24
Reporting Period:
2017-05-11
Filing Date:
2017-05-15
Accepted Time:
2017-05-15 20:13:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1005201 Depomed Inc DEPO Pharmaceutical Preparations (2834) 943229046
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1367754 M Matthew Gosling C/O Depomed, Inc.
7999 Gateway Boulevard, Suite 300
Newark CA 94560
Svp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-05-11 59,212 $11.37 20,665 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares at each price within the range set forth in this footnote.